Evgen Pharma Share Discussion Threads

[clocktower] 11/4/2024 15:41

Another substantial holding to make the fourth now declared, and what may become interesting, is how many shares will be in general free float, rather than what might be considered as safe long term hands,

[theresalwaysone] 09/4/2024 15:41

I think if you drop below 3% you have to announce it

[clocktower] 09/4/2024 15:18

So shareholders now know that there are three holders of more than 3% but I guess the rest that were previously listed have dropped below the 3% or might have been earlier sellers, which has driven the share price down further.

I wonder why the delay in changing name, although they stated on 4 April there would be a further announcement regarding that.

[clocktower] 08/4/2024 16:04

lovewin.... I doubt if any of the directors will be buying to put them in their ISA type investments even at the current bid either, as you say they have only coughed up pocket money to participate in the funding at 1p.

If they were doing so, or those close to them I think you would have seen decent buy volumes today, anyway best of luck if your still sitting on a nest egg, that may or may not hatch one distant day with the Stal deal or something else.

[lovewinshatelosses] 08/4/2024 10:15

Perhaps he is locked in, so could not sell without losing tax advantages? IMO, if you had this big a position and retained faith in the business, you would not let yourself be diluted, so IMO it cannot be taken as a positive.
Inside buying levels were buttons, especially taking everything into consideration, so also not a positive either, IMO.
But we are into a new tax year, so hopefully can make enough profit in credible outfits in the months ahead, to offset the loss that this typical AIM POS is going to result in. IMO, more chance of winning the lottery than seeing this one become a commercial success. Obviously there might be the odd spike on the way to oblivion as usually happens in these types, but virtually zero chance of this one not going the way of similar lifestyle gigs in this space IMO. If miracles happen, I might get the chance to take a smaller loss in this period, but not banking on it. GLA while we wait to see confirmation of what most of us now deem the likely outcome for Stal. And which, IMO, this recent stinker of a raise was actually made for - to keep the lights on and salaries paid, for as long as possible.

[clocktower] 05/4/2024 17:26

Over 1% at 0.80 - 5,000,000 @ 11.01.58 today shown up well after close.

Buy or Sell ?

[clocktower] 05/4/2024 14:49

Well J R Kight still has all his 33,100.000 shares but never added in the raise it seems.

[markth126] 04/4/2024 17:34

Stock transfer form last was axa

[clocktower] 04/4/2024 17:18

TR1 ? For what markth126

[markth126] 04/4/2024 17:12

I understand no TR1 have been received

[clocktower] 04/4/2024 17:04

Current:

J. R. Kight 33,100,000 12.0%
Octopus Investments 21,875,000 8.0%
SPARK Impact 16,186,446 5.9%
Seneca Investment Managers 14,932,071 5.4%
AXA Framlington 13,399,724 4.87%
Chelverton Asset Management 12,500,000 4.5%
RAB Capital 8,750,000 3.2%
Newlands Capital 8,314,815 3.0%

[clocktower] 04/4/2024 17:00

1p paid I notice - MM making a killing.

TCF for the a new thread.

It should have been TCP (antiseptic) to sooth pain, and there has been a lot of that in this share to date.

When they update the shareholder info on the new website, it should make interesting reading.

[clocktower] 04/4/2024 16:04

hat if you were the bigger seller today, I am surprised you waited this long.

Still, those buying today may get better luck than we did, when it starts trading under the new TIDM, which I guess will be next week.

Good Luck to all that sail in the new ship.

PS hat, I still think it is undervalued at under 1p but HJ is the problem - greed and misleading.

[abbynat] 04/4/2024 11:18

administration!

[manual dexterity] 04/4/2024 08:49

I'm afraid I agree. £51k is paltry and really poor. No idea where this is going now.

Limbo?

[hatfullofsky] 04/4/2024 08:47

Clock - you wroteI disagree hat, at just 1p the combined business is going to be worth a lot more than £5.5 million. If Stalicla goes ahead without a serious hitch, the potential still undervalues the company , at least it would be three times the current price, and that is without any licensing deals that the earn out seems to be based upon.If there was a few deals with this compound, who knows how the market might value it.You may want to take the rose tinted glasses off

[hatfullofsky] 04/4/2024 07:08

Even worse than I expected"I think they will be very lucky to get anywhere near GBP1m from PIs. GBP100k more likely"GBP51k raisedPathetic, Huw is living in cuckoo land, he has shafted private shareholders and they have reacted accordingly

[lovewinshatelosses] 26/3/2024 16:59

I look forward to reading those timbo, but the trust is gone and I am not sure, for me anyway, it can be regained now.
He talks a good game, but this recent raise comes across as simply desperate IMO and the inside buying, too little too late.
Still have the rump holding, so perhaps might be inclined to leave those alone, going into the new tax year, but as for buying more? Highly unlikely. We are long past the stage of fool me once territory!

[timbo003] 26/3/2024 15:03

I spoke to HJ for around 30 mins on the phone this morning, he had got in contact with me after I left my contact details on the IMC feedback form. He answered most of my outstanding questions, so I will have a go at writing up a few brief notes this evening.

[clocktower] 26/3/2024 14:49

Might even see a blue day tomorrow.

[clocktower] 26/3/2024 12:54

The market is crazy - EVG now valued at less than £2.5m - SFX-01 has surely got to be worth more than this bearing mind what they have already achieved.

Tempting.

[timbo003] 26/3/2024 12:06

I heard this morning (from the horse's mouth) that Evgen are intending to hold a face to face capital markets type day in London, sometime between the two May bank holidays. It is intended to make it open to retail shareholders (although places may be limited) 🙂

[clocktower] 21/3/2024 13:28

Recruiting:



"Our lead program focuses on an autism subtype called 'ASD Phenotype 1' and we are currently recruiting for clinical trials."

Just a thought:

Rather than Stalicla paying the sums in dispute would they be considering buying all rights to SFX-01 outright, hence the need for another asset purchase and name change?